Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.

Saved in:
Bibliographic Details
Title: Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.
Authors: Crawford TB; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Tayeb M; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Barrett E; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Al-Saleem T; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA., Kondam P; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hausler R; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Symecko H; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Orr C; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Wolfe CS; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Mann D; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Spielman K; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Wong G; 4Division of Urology, Department of Surgical and Peri-operative Care, VA Greater Los Angeles Healthcare System, Los Angeles, CA., Haas NB; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Narayan V; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Robinson K; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Takvorian S; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Wong YN; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sokolova AO; 5Puget Sound VA Medical Center, Seattle, WA.; 6Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA., Montgomery RB; 5Puget Sound VA Medical Center, Seattle, WA.; 6Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA.; 7Fred Hutchison Cancer Center, Seattle, WA., Menendez C; 8Durham VA Health System, Durham, NC.; 9Department of Surgery, Duke University Medical Center, Durham, NC., Kelley MJ; 8Durham VA Health System, Durham, NC.; 10Division of Medical Oncology, Duke University School of Medicine, Durham, NC., Aiello LB; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA., Garraway IP; 4Division of Urology, Department of Surgical and Peri-operative Care, VA Greater Los Angeles Healthcare System, Los Angeles, CA.; 11Department of Urology, University of California Los Angeles, Los Angeles, CA., Domchek SM; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Maxwell KN; 1Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; 2Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; 3Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Jun 02; Vol. 24 (7). Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-1413
DOI:10.6004/jnccn.2026.7006